Role of Pioglitazone in Type 2 Diabetes Management
Introduction to Pioglitazone
- Pioglitazone should be considered as a second-line agent after metformin in type 2 diabetes management, particularly in patients with nonalcoholic steatohepatitis (NASH) or those at high cardiovascular risk where its pleiotropic effects may provide additional benefits beyond glycemic control 1, 2
Place in Therapy
- First-line therapy should be metformin plus lifestyle modifications (diet, exercise, weight loss) 1, 2
- The American College of Physicians strongly recommends adding a second agent to metformin when lifestyle modifications and metformin monotherapy fail to control hyperglycemia 2
- Pioglitazone is recommended as a second-tier therapy when metformin alone fails to achieve glycemic targets 3
Efficacy and Benefits
- Reduces HbA1c levels to a similar degree as other diabetes medications 2
- Provides favorable effects on lipid profile, including increasing HDL cholesterol levels and decreasing triglyceride levels 4, 5
- Reverses steatohepatitis in patients with NASH and type 2 diabetes, and improves liver histology and may slow fibrosis progression 6, 7
Adverse Effects and Precautions
- Associated with increased risk for heart failure due to fluid retention 2
- Contraindicated in patients with serious heart failure 2
- Increased risk of fractures, particularly in women 8
- Low risk of hypoglycemia compared to sulfonylureas 2